Application of mTOR inhibitor and anti-cancer drug
A technology of anti-cancer drugs and kinase inhibitors, which is applied in the field of combined use of mTOR inhibitors and anti-cancer drugs, can solve problems such as toxic side effects and drug resistance, achieve inhibition of proliferation, enhancement of inhibitory activity, and wide application value Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] The salivary gland adenoid cystic carcinoma cell SACC-LM of the present invention is cryopreserved in the laboratory, conventionally cultivated in DMEM / HighGlucose complete culture medium [containing calf serum 10% (volume fraction), penicillin 10% 5 U / L, streptomycin 100mg / L].
[0032] Such as figure 1 As shown, the composition of PKD1 mediated mTOR inhibitor and anticancer drug provided by the present invention and its application
[0033] S101, Western blot detection of PKD1 expression in different adenocarcinoma cell lines;
[0034] S102, CCK8 detects the inhibitory rate of different concentrations of PTX on the adenocarcinoma cell line SACC-LM cells;
[0035] S103, CCK8 detect the inhibitory rate of RAD001 and PTX acting separately / combinedly on SACC-LM cells
[0036] S104, Western blot detection of PKD1 phosphorylation, activation and expression of RAD001 and PTX separately / cooperatively in SACC-LM cells
[0037] S105, Western blot detection of the expression of...
Embodiment 2
[0094] Take RAD001 and PTX, suitable filling agent, after mixing, prepare capsules.
Embodiment 3
[0096] Take RAD001 and PTX, appropriate fillers, binders, and lubricants to prepare granules.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


